Global law firm Ashurst has advised Vector Innovation Fund (VIF) on the launch of a $300 million pandemic protection sub-fund.

VIF is a Reserved Alternative Investment Fund based in Luxembourg, and this is their first advanced technology focused sub-fund which aims to invest in technologies for pandemic protection and future healthcare, aiding and supporting precision medicine, highly advanced point of care and AI technologies to support the global economy, sustainable healthcare, and life longevity.

The Ashurst team was led by investment funds partner Antonios Nezeritis, supported by associate Frank Noesen.

Antonios Nezeritis commented:

“Investment in healthcare will continue to grow following the impacts of the Covid-19 virus and VIF’s focus on investing in sophisticated and transformation technologies is a great example of this. We are very pleased to have assisted them in the launch of this important fund.”